Assignee
ALTEOGEN INC
KR12 patents
Top patents by PatentIndex Score
US9982032B2May 29, 2018
Stable liquid formulation of fusion protein with IgG Fc domain
ALTEOGEN INC19 citations92
US9814782B2Nov 14, 2017
Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for same
ALTEOGEN INC10 citations76
US9474803B2Oct 25, 2016
Composition for stabilizing fusion protein in which protein and FC domain are fused
ALTEOGEN INC5 citations71
US11235065B2Feb 1, 2022
Antibody-drug conjugate comprising modified antibody
ALTEOGEN INC2 citations69
US12371683B2Jul 29, 2025
Hyaluronidase variants and pharmaceutical composition comprising the same
ALTEOGEN INC1 citations60
US12090210B2Sep 17, 2024
Antibody-drug conjugate comprising modified antibody
ALTEOGEN INC0 citations59
US11866492B2Jan 9, 2024
Antibody specifically binding to FOLR1 and uses thereof
ALTEOGEN INC0 citations59
US12570766B2Mar 10, 2026
Pharmaceutical composition for subcutaneous administration containing human hyaluronidase PH20 variant and drug
ALTEOGEN INC0 citations56
US11414476B2Aug 16, 2022
Method for producing fusion protein having IgG Fc domain
ALTEOGEN INC1 citations55
US11981719B2May 14, 2024
Growth hormone receptor antagonists and fusion proteins thereof
ALTEOGEN INC0 citations52
US9821059B2Nov 21, 2017
Composition for stabilizing protein and pharmaceutical formulation comprising the same
ALTEOGEN INC0 citations46
US12221638B2Feb 11, 2025
Method for producing recombinant hyaluronidase
ALTEOGEN INC0 citations41